TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.290
-0.070 (-5.15%)
Dec 23, 2024, 4:00 PM EST - Market closed
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,819,489
Market Cap
3.55M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | -3 | -33.33% |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Check-Cap | 85 |
Nuwellis | 59 |
HeartSciences | 15 |
Sonoma Pharmaceuticals | 10 |
Channel Therapeutics | 8 |
180 Life Sciences | 4 |
Creative Medical Technology Holdings | 4 |
GT Biopharma | 2 |
TNFA News
- 4 days ago - TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs - Business Wire
- 14 days ago - TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference - Business Wire
- 2 months ago - TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market - Business Wire
- 4 months ago - TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline - Business Wire
- 5 months ago - TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today - Business Wire
- 5 months ago - MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. - Business Wire
- 6 months ago - MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer - Business Wire
- 7 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire